tanshinone ii a has been researched along with 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione in 1 studies
Studies (tanshinone ii a) | Trials (tanshinone ii a) | Recent Studies (post-2010) (tanshinone ii a) | Studies (4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione) | Trials (4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione) | Recent Studies (post-2010) (4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione) |
---|---|---|---|---|---|
61 | 0 | 41 | 126 | 1 | 84 |
Protein | Taxonomy | tanshinone ii a (IC50) | 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (IC50) |
---|---|---|---|
[tau protein] kinase | Oryctolagus cuniculus (rabbit) | 2 | |
G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | 10 | |
Cyclin-dependent kinase 1 | Homo sapiens (human) | 10 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 2.15 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 1.145 | |
G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 10 | |
Glycogen synthase kinase-3 alpha | Homo sapiens (human) | 4.5 | |
Glycogen synthase kinase-3 beta | Homo sapiens (human) | 2.0608 | |
G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | 10 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
1 other study(ies) available for tanshinone ii a and 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione
Article | Year |
---|---|
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |